Updates
Stay informed on Expora's latest milestones, scientific breakthroughs, and partnership announcements.
Recent Posts
See What's New
From preclinical breakthroughs to regulatory progress, explore how we're advancing BEVs to improve human health
BEVs show promise for IBD treatment but consistent, scalable manufacturing remains the critical barrier preventing clinical translation.
Expora's founders invent biotechnology to overcome a critical BEV manufacturing hurdle
Expora secures TEDCO funding to advance targeted IBD therapies, led by co-founder Dr. Nicholas Pirolli. A new era in inflammation treatment begins.
Recent Posts
See What's New
From preclinical breakthroughs to regulatory progress, explore how we're advancing BEVs to improve human health
BEVs show promise for IBD treatment but consistent, scalable manufacturing remains the critical barrier preventing clinical translation.
Expora's founders invent biotechnology to overcome a critical BEV manufacturing hurdle
Expora secures TEDCO funding to advance targeted IBD therapies, led by co-founder Dr. Nicholas Pirolli. A new era in inflammation treatment begins.
Recent Posts
See What's New
From preclinical breakthroughs to regulatory progress, explore how we're advancing BEVs to improve human health
BEVs show promise for IBD treatment but consistent, scalable manufacturing remains the critical barrier preventing clinical translation.
Expora's founders invent biotechnology to overcome a critical BEV manufacturing hurdle
Expora secures TEDCO funding to advance targeted IBD therapies, led by co-founder Dr. Nicholas Pirolli. A new era in inflammation treatment begins.